Illustrative sample. A fictional composite client for demonstration. Not a real person and not medical advice. Every client receives this same document from their own data.

Clinical Summary

Sample Client

Prepared August 28, 2026

This summary is prepared for the client to share with their physician. It is contextual coaching data, not a diagnosis or medical advice. Any clinical or medication decision is between the patient and their physician.

Summary

This client's lifestyle drivers, Chronic stress load (34% of modeled drivers) and Nutrition / metabolic structure, converge with their genetics (a loaded methylation pathway (under-methylation pressure, high homocysteine risk); carbohydrate / insulin-sensitivity variants; a cardiovascular lipid-handling variant) on the same downstream systems. Their self-directed supplement stack (6 of 8 taken currently; 2 listed but at 0% adherence) targets these mechanisms (reason and adherence per item in the table). Bloodwork that would confirm or refute this convergence: glycemic, methylation, lipid, inflammation, micronutrient. Contextual coaching data, not a diagnosis; clinical and medication decisions are the physician's.

Working focus

Chronic stress load

Current supplements & peptides

Supplement	Dose	Timing	Adherence	Reason
Folate (5-MTHF)	400 to 800 mcg/day	Morning	96% · n=28	Supports Folate Cycle & 5-MTHF Production, Methionine Cycle & SAM Synthesis
Methylcobalamin (B12)	1000 mcg/day	Morning	93% · n=28	Supports B12-dependent homocysteine remethylation
Magnesium Glycinate	200 to 400 mg	Evening	100% · n=30	Supports ATP Synthesis via Chemiosmosis
Creatine Monohydrate	5 g	Morning	100% · n=30	Supports ATP resynthesis and cognitive load tolerance
Omega-3 (EPA/DHA)	2 g	Morning	61% · n=23	Supports membrane composition and inflammatory balance
Vitamin D3 + K2	2000 IU	Morning	71% · n=24	Addresses a mechanism that is not a current constraint for this client
Ashwagandha	600 mg	Evening	0% · n=22 (not taking)	Supports HPA-axis regulation and stress-load recovery
Berberine	500 mg	With meals	0% · n=26 (not taking)	Supports insulin signaling and glycemic control

Adherence = taken ÷ logged days over a 30-day window; n is the number of days actually logged (a small n is a thin estimate). Items marked 0% are listed but not currently being taken.

Labs on file

Marker	Value	Flag	Date	Lab
Fasting glucose	96 mg/dL	optimal	2026-06-14	Quest
Fasting insulin	9.4 uIU/mL	high	2026-06-14	Quest
Homocysteine	11.2 umol/L	high	2026-06-14	Quest
hs-CRP	1.8 mg/L	high	2026-06-14	Quest
25-OH Vitamin D	34 ng/mL	low	2026-06-14	Quest

Flags reflect functional-optimal ranges, not lab reference ranges. Clinical interpretation is the physician's.

Biometric trends

Marker	Latest	Avg	Trend	n
HRV	48 ms	46	↑	9
Resting HR	58 bpm	59	→	9
Sleep	6.4 hrs	6.9	↓	9
Weight	178 lbs	179	→	9

n is the observation count; a small n (e.g. n=5) is a thin estimate, not a stable trend.

Genetic considerations

Ordered by evidence strength. Well-established = strong, replicated evidence · Plausible = functional but modest replication · Exploratory = candidate-gene, planning signal only.

establishedTCF7L2 (CT)rs7903146 · Moderate glucose risk: TCF7L2 carries the strongest common genetic signal for carbohydrate sensitivity; variants may make the insulin response to refined carbs and high-glycemic meals more pronounced than average.

establishedAPOE (E3/E4)rs429358, rs7412 · APOE e3 e4: one E4 allele may shift how dietary fat and cholesterol are transported and cleared, influencing lipid response to saturated fat and long-term cardiovascular risk framing.

establishedMTHFR (AG)rs1801133 · Moderate reduced folate conversion: MTHFR variants may reduce the enzyme activity that converts folate to its active form, affecting methylation efficiency and recovery nutrient demand.

establishedCOMT (AA)rs4680 · Slower catecholamine clearance: COMT variants may influence how quickly dopamine and norepinephrine are cleared, affecting stress tolerance, focus under pressure, and stimulant response.

establishedCYP1A2 (AC)rs762551 · Intermediate caffeine clearance: CYP1A2 sets how long caffeine, melatonin, and several medications stay active, not just coffee timing.

establishedMC4R (CC)rs17782313 · Higher satiety risk: the C/C genotype near MC4R is associated with modestly higher appetite and energy intake and a higher-BMI tendency.

plausibleMTRR (AG)rs1801394 · Moderate B12 recycling load: MTRR variants may affect the regeneration of active B12 used in the methionine cycle, compounding with MTHFR status when both are present.

plausibleFKBP5 (CT)rs1360780 · Heightened stress axis reactivity: the intron-2 T allele may raise FKBP5 induction and reduce glucocorticoid-receptor sensitivity, a pattern associated with slower cortisol recovery.

plausibleCYP1B1 (CG)rs1056836 · Catechol-estrogen formation context: CYP1B1 variants may influence the formation of 4-hydroxy catechol-estrogens, shifting estrogen metabolism toward more reactive metabolites.

plausibleTCN2 (CG)rs1801198 · Mild reduced B12 transport: TCN2 variants may affect the transport protein that carries B12 into cells, so serum B12 can look normal even when cellular delivery is limited.

exploratoryIL6 (GG)rs1800795 · Higher inflammatory response context: the -174 G/G genotype is associated with higher baseline IL-6 expression and inflammatory tone.

exploratorySOD2 (CC)rs4880 · Mitochondrial redox load: SOD2 variants may alter the mitochondrial targeting of superoxide dismutase 2, increasing reliance on downstream glutathione and selenium-dependent defenses.

Every variant here was directly genotyped from this client's array. Genetic findings describe predispositions, not certainties.

Methylation systems view

Net lean: Under-Methylation PressureNet pressure: 64.2 / 100 (synthesized index)Homocysteine risk: HighMethyl-donor tolerance: Low

The methyl pool reads as supply-limited: several genes on the remethylation/folate arm run slow, and two draw the pool down. Homocysteine risk is high. Clearance is slow (slow COMT): the constraint is substrate load, not methyl excess.

Supply-limiting (remethylation / folate arm): MTHFR (AG), MTRR (AG), TCN2 (CG)

Drawing the pool down: MTHFD1 (AG), PEMT (TT)

A working model synthesized from the named methylation-pathway variants (predicted, not measured); the net-pressure index is a 0–100 synthesis of supply-deficit and demand-load. Confirm with the methylation labs below.

Suggested labs to consider

Markers that would confirm or refute where this client's current constraints converge. A discussion list for the physician, not a test order.

glycemic

Fasting glucoseFasting insulinHbA1c

methylation

HomocysteineSerum B12 (+ active/holoTC)RBC folateMethylmalonic acid (MMA)

lipid

Lipid panel with ApoBLp(a)

inflammation

hs-CRP

micronutrient

25-OH Vitamin DRBC magnesium

Daily protocol

Blue-light blockers on 90 min before bed
10-minute morning daylight exposure within 30 min of waking
Protein-forward first meal (30 to 40 g)

Human Growth Factor · Contextual, evidence-based coaching. Not a diagnosis or medical advice.